Tyrosine Kinase Inhibitors Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
Report Highlights
Tyrosine Kinase Inhibitors Market - Overview
This report on the tyrosine kinase inhibitors market analyzes the current and future scenario of the global market. Increasing expenditure on health care, high prevalence and rise in incidence of cancer, and rise in demand for tyrosine kinase inhibitors for lungs cancer & breast cancer treatment are boosting the usage of tyrosine kinase inhibitors. Health benefits of tyrosine kinase inhibitors and focus of companies on expanding indications of existing and pipeline TKIs are major drivers of the global tyrosine kinase inhibitors market.
The tyrosine kinase inhibitors market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, application, distribution channel, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Additionally, the section comprises product portfolios of major players, based on constituents & application, in order to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography, and market share analysis by key players. Thus, presenting a thorough analysis of the overall competitive scenario in the global tyrosine kinase inhibitors market.
Based on product, the market has been segmented into BCR-ABL tyrosine kinase inhibitor, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, vascular endothelial growth factor (VEGFR) tyrosine kinase inhibitors, and other tyrosine kinase inhibitors. The product segment of tyrosine kinase inhibitors market has been analyzed based on available approved products, cost-effectiveness, and preference provided by physicians and patients in treating different cancer diseases. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the period from 2018 to 2026, considering 2017 as the base year.
Based on application, the market has been classified into chronic myeloid leukemia (CML), lung cancer, breast cancer, renal cell cancer, and others. The application segment of tyrosine kinase inhibitors market has been analyzed based on the prevalence of disease and usage of tyrosine kinase inhibitors in treatment. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the period from 2018 to 2026, considering 2017 as the base year.
In terms of distribution channel, the tyrosine kinase inhibitors market has been segregated into hospital pharmacies, independent pharmacies, and online pharmacies. The market segments have been extensively analyzed based on prevalence of the diseases and usage of tyrosine kinase inhibitors during available treatment and expansion of international pharmacy service providers across the globe. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the period from 2018 to 2026, considering 2017 as the base year.
In terms of geography, the global tyrosine kinase inhibitors market has been categorized into six major regions and the key countries in the respective region are: North America (U.S., Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, Australia & New Zealand and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East (UAE, Saudi Arabia, and Rest of Middle East) and Africa (South Africa and Rest of Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.
The report also profiles major players in the global tyrosine kinase inhibitors market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include AstraZeneca Plc, Pfizer, Inc., Novartis AG, Bristol-Myers Squibb Company, Bayer AG, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Eisai Co., Ltd., and Eurofarma Laboratórios S/A.
Global tyrosine kinase inhibitors market has been segmented as given below:
Global Tyrosine Kinase Inhibitors Market, by Product, 2016?2026
BCR-ABL Tyrosine Kinase Inhibitors
Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
Vascular Endothelial Growth Factor (VEGFR) Tyrosine Kinase Inhibitors
Other Tyrosine Kinase Inhibitors (Janus Kinase Inhibitors, Bruton’s Kinase Inhibitor, HGFR TKIs, ALK / ROS1 TKIs, etc.)
Global Tyrosine Kinase Inhibitors Market, by Application, 2016?2026
Chronic Myeloid Leukemia (CML)
Lung Cancer
Breast Cancer
Renal Cell Cancer
Others
Global Tyrosine Kinase Inhibitors Market, by Distribution Channel, 2016?2026
Hospital Pharmacies
Independent Pharmacies
Online Pharmacies
Global Tyrosine Kinase Inhibitors Market, by Geography, 2016?2026
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East
Saudi Arabia
UAE
Rest of Middle East
Africa
South Africa
Rest of Africa
- Table 1 : Global BCR-ABL Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Key Brands, 2016-2026
- Table 2 : Global EGFR Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Key Brands, 2016-2026
- Table 3 : Global VEGFR Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Key Brands, 2016-2026
- Table 4 : Global Other Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Key Brands, 2016-2026
- Table 5 : Patent & Market Exclusivity Overview, by Molecule (1/4)
- Table 6 : Patent & Market Exclusivity Overview, by Molecule (2/4)
- Table 7 : Patent & Market Exclusivity Overview, by Molecule (3/4)
- Table 8 : Patent & Market Exclusivity Overview, by Molecule (4/4)
- Table 9 : Overview of Indications Approved, by Molecule (1/8)
- Table 10 : Overview of Indications Approved, by Molecule (2/8)
- Table 11 : Overview of Indications Approved, by Molecule (3/8)
- Table 12 : Overview of Indications Approved, by Molecule (4/8)
- Table 13 : Overview of Indications Approved, by Molecule (5/8)
- Table 14 : Overview of Indications Approved, by Molecule (6/8)
- Table 15 : Overview of Indications Approved, by Molecule (7/8)
- Table 16 : Overview of Indications Approved, by Molecule (8/8)
- Table 17 : BCR-ABL Tyrosine Kinase Inhibitors Pipeline Analysis (1/2)
- Table 18 : BCR-ABL Tyrosine Kinase Inhibitors Pipeline Analysis (2/2)
- Table 19 : EGFR Tyrosine Kinase Inhibitors Pipeline Analysis
- Table 20 : VEGFR Tyrosine Kinase Inhibitors Pipeline Analysis (1/3)
- Table 21 : VEGFR Tyrosine Kinase Inhibitors Pipeline Analysis (2/3)
- Table 22 : VEGFR Tyrosine Kinase Inhibitors Pipeline Analysis (3/3)
- Table 23 : Multi-target Tyrosine Kinase Inhibitors Pipeline Analysis
- Table 24 : Bruton’s Tyrosine Kinase Inhibitors Pipeline Analysis (1/2)
- Table 25 : Bruton’s Tyrosine Kinase Inhibitors Pipeline Analysis (2/2)
- Table 26 : Aurora Tyrosine Kinase Inhibitors Pipeline Analysis
- Table 27 : Other Tyrosine Kinase Inhibitors Pipeline Analysis (1/3)
- Table 28 : Other Tyrosine Kinase Inhibitors Pipeline Analysis (2/3)
- Table 29 : Other Tyrosine Kinase Inhibitors Pipeline Analysis (3/3)
- Table 30 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Product, 2016–2026
- Table 31 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2016–2026
- Table 32 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 33 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Region, 2016–2026
- Table 34 : North America Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Product, 2016–2026
- Table 35 : North America Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2016–2026
- Table 36 : North America Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 37 : North America Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country, 2016–2026
- Table 38 : Europe Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Product, 2016–2026
- Table 39 : Europe Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2016–2026
- Table 40 : Europe Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 41 : Europe Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
- Table 42 : Asia Pacific Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Product, 2016–2026
- Table 43 : Asia Pacific Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2016–2026
- Table 44 : Asia Pacific Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 45 : Asia Pacific Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
- Table 46 : Latin America Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Product, 2016–2026
- Table 47 : Latin America Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2016–2026
- Table 48 : Latin America Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 49 : Latin America Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
- Table 50 : Middle East Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Product, 2016–2026
- Table 51 : Middle East Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2016–2026
- Table 52 : Middle East Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Table 53 : Middle East Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
- Table 54 : Africa Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Product, 2016–2026
- Table 55 : Africa Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Application, 2016–2026
- Table 56 : Africa Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
- Figure 1 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Distribution, by Region, 2017 and 2026
- Figure 2 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
- Figure 3 : Global Tyrosine Kinase Inhibitors Market Value Share, by Product Type (2017)
- Figure 4 : Global Tyrosine Kinase Inhibitors Market Value Share, by Application (2017)
- Figure 5 : Global Tyrosine Kinase Inhibitors Market Value Share, by Distribution Channel (2017)
- Figure 6 : Global Tyrosine Kinase Inhibitors Market Value Share, by Region (2017)
- Figure 7 : Clinical Trial Analysis by Phase
- Figure 8 : Clinical Trial Analysis by Status
- Figure 9 : Clinical Trial Analysis by Completion and Termination Rate
- Figure 10 : Clinical Trial Analysis by Region
- Figure 11 : Global Tyrosine Kinase Inhibitors Market Value Share Analysis, by Product, 2017 and 2026
- Figure 12 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by BCR-ABL TKIs, 2016–2026
- Figure 13 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by EGFR TKIs, 2016–2026
- Figure 14 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by VEGFR TKIs, 2016–2026
- Figure 15 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth, by Other TKIs, 2016–2026
- Figure 16 : Global Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Product, 2018–2026
- Figure 17 : Global Tyrosine Kinase Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
- Figure 18 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by CML, 2016–2026
- Figure 19 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lung Cancer, 2016–2026
- Figure 20 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Renal Cell Cancer, 2016–2026
- Figure 21 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Breast Cancer, 2016–2026
- Figure 22 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
- Figure 23 : Global Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Application, 2018–2026
- Figure 24 : Global Tyrosine Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
- Figure 25 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies, 2016–2026
- Figure 26 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacies, 2016–2026
- Figure 27 : Global Tyrosine Kinase Inhibitors Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies, 2016–2026
- Figure 28 : Global Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2018–2026
- Figure 29 : Global Tyrosine Kinase Inhibitors Market Value Share Analysis, by Region/Country, 2017 and 2026
- Figure 30 : Global Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Region/Country, 2018–2026
- Figure 31 : North America Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
- Figure 32 : North America Tyrosine Kinase Inhibitors Market Value Share Analysis, by Product, 2017 and 2026
- Figure 33 : North America Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Product, 2018–2026
- Figure 34 : North America Tyrosine Kinase Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
- Figure 35 : North America Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Application, 2018?2026
- Figure 36 : North America Tyrosine Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
- Figure 37 : North America Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2018?2026
- Figure 38 : North America Tyrosine Kinase Inhibitors Market Value Share Analysis, by Country, 2017 and 2026
- Figure 39 : North America Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Country, 2018–2026
- Figure 40 : Europe Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
- Figure 41 : Europe Tyrosine Kinase Inhibitors Market Value Share Analysis, by Product, 2017 and 2026
- Figure 42 : Europe Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Product, 2018–2026
- Figure 43 : Europe Tyrosine Kinase Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
- Figure 44 : Europe Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Application, 2018?2026
- Figure 45 : Europe Tyrosine Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
- Figure 46 : Europe Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2018?2026
- Figure 47 : Europe Tyrosine Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
- Figure 48 : Europe Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
- Figure 49 : Asia Pacific Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
- Figure 50 : Asia Pacific Tyrosine Kinase Inhibitors Market Value Share Analysis, by Product, 2017 and 2026
- Figure 51 : Asia Pacific Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Product, 2018–2026
- Figure 52 : Asia Pacific Tyrosine Kinase Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
- Figure 53 : Asia Pacific Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Application, 2018?2026
- Figure 54 : Asia Pacific Tyrosine Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
- Figure 55 : Asia Pacific Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Distribution Channel, 2018?2026
- Figure 56 : Asia Pacific Tyrosine Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
- Figure 57 : Asia Pacific Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
- Figure 58 : Latin America Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
- Figure 59 : Latin America Tyrosine Kinase Inhibitors Market Value Share Analysis, by Product, 2017 and 2026
- Figure 60 : Latin America Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Product, 2018–2026
- Figure 61 : Latin America Tyrosine Kinase Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
- Figure 62 : Latin America Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Application, 2018 -2026
- Figure 63 : Latin America Tyrosine Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
- Figure 64 : Latin America Tyrosine Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
- Figure 65 : Latin America Tyrosine Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
- Figure 66 : Latin America Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
- Figure 67 : Middle East Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
- Figure 68 : Middle East Tyrosine Kinase Inhibitors Market Value Share Analysis, by Product, 2017 and 2026
- Figure 69 : Middle East Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Product, 2018–2026
- Figure 70 : Middle East Tyrosine Kinase Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
- Figure 71 : Middle East Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Application, 2018 -2026
- Figure 72 : Middle East Tyrosine Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
- Figure 73 : Middle East Tyrosine Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018 - 2026
- Figure 74 : Middle East Tyrosine Kinase Inhibitors Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
- Figure 75 : Middle East Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
- Figure 76 : Africa Tyrosine Kinase Inhibitors Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
- Figure 77 : Africa Tyrosine Kinase Inhibitors Market Value Share Analysis, by Product, 2017 and 2026
- Figure 78 : Africa Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Product, 2018–2026
- Figure 79 : Africa Tyrosine Kinase Inhibitors Market Value Share Analysis, by Application, 2017 and 2026
- Figure 80 : Africa Tyrosine Kinase Inhibitors Market Attractiveness Analysis, by Application, 2018?2026
- Figure 81 : Africa Tyrosine Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2017 and 2026
- Figure 82 : Africa Tyrosine Kinase Inhibitors Market Value Share Analysis, by Distribution Channel, 2018?2026
- Figure 83 : Global Tyrosine Kinase Inhibitors Market Share, by Company, 2017
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.